(Q43585230)

24 November 2017

Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia (English)

1 reference

24 November 2017

0 references

0 references

1 reference

Segman RH

1

1 reference

24 November 2017

Heresco-Levy U

2

1 reference

24 November 2017

Finkel B

3

1 reference

24 November 2017

Goltser T

4

1 reference

24 November 2017

Shalem R

5

1 reference

24 November 2017

Schlafman M

6

1 reference

24 November 2017

Dorevitch A

7

1 reference

24 November 2017

Yakir A

8

1 reference

24 November 2017

Greenberg D

9

1 reference

24 November 2017

Lerner A

10

1 reference

24 November 2017

Lerer B

11

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

24 November 2017

1 reference

24 November 2017

6

1 reference

24 November 2017

225-229

1 reference

24 November 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.mp.4000842

24 November 2017

0 references

cites work

Tardive dyskinesia: prevalence and risk factors, 1959 to 1979.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

The role of serotonin in antipsychotic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

Two naturally occurring amino acid substitutions of the 5-HT2A receptor: similar prevalence in patients with seasonal affective disorder and controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

Homozygosity for the Gly-9 variant of the dopamine D3 receptor and risk for tardive dyskinesia in schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

[3H]ketanserin binding in human brain postmortem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

The role of 5-HT2A receptors in antipsychotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

Implications of Amphetamine-Induced Stereotyped Behavior as a Model for Tardive Dyskinesias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

The serotonin receptor subtype 2 locus HTR2 is on human chromosome 13 near genes for esterase D and retinoblastoma-1 and on mouse chromosome 14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

Analysis of the 5'-flanking promoter region of the 5-HT2A receptor gene in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

No correlation between A(-1438)G polymorphism in 5-HT2A receptor gene promoter and the density of frontal cortical 5-HT2A receptors in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

Negative association between T102C polymorphism of the 5-HT2a receptor gene and schizophrenia in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

Risk factors for orofacial and limbtruncal tardive dyskinesia in older patients: a prospective longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

Topographic subtypes of tardive dyskinesia in schizophrenic patients aged less than 60 years: relationship to demographic, clinical, treatment, and neuropsychological variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

Heterogeneity of tardive dyskinesia. A multivariate analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

Association between 5-HT2A gene promoter polymorphism and anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

5-HT2A receptor gene polymorphisms in anorexia nervosa and bulimia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

An MspI polymorphism in the hyman serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

7 January 2021

The effect of haloperidol feeding on dopamine receptor number in ten mouse strains

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

7 January 2021

Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

7 January 2021

Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

7 January 2021

The effect of novel antipsychotics in rat oral dyskinesia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

7 January 2021

Subthalamic nucleus microinjections of 5-HT2 receptor antagonists suppress stereotypy in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

7 January 2021

Serotonin neural adaptations to ontogenetic loss of dopamine neurons in rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

7 January 2021

Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

7 January 2021

Association between allele 1 of T102C polymorphism, 5-hydroxytryptamine 2a receptor gene and schizophrenia in Chinese males in Singapore

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

7 January 2021

No association or linkage between the 5-HT2a/T102C polymorphism and schizophrenia in Irish families

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

7 January 2021

Schizophrenia and the serotonin-2A receptor promoter polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

7 January 2021

Lack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

7 January 2021

Extrapyramidal syndromes in neuroleptic-treated patients: prevalence, risk factors, and association with tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4000842

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4000842

1 reference

release_l6npdaarpvh4bhivgtry2zfzhy

24 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/l6npdaarpvh4bhivgtry2zfzhy

24 November 2022

mapped directly with Wikidata item

1 reference